Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycolix Glyco-Urea KP Therapy
- Development stage
- Unknown
- Lead developer
- Topix Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Glycolix Glyco-Urea KP Therapy is a topical skincare cream developed and launched by Topix Pharmaceuticals in May 2018. The product is a combination therapy containing 15% glycolic acid and 15% urea, specifically formulated to treat hyperkeratotic skin conditions such as keratosis pilaris (KP), psoriasis, and dermatitis. Glycolic acid, an alpha-hydroxy acid, acts as a chemical exfoliant to remove dead skin cells and smooth skin texture. Urea serves as a potent humectant that moisturizes and replenishes the skin barrier. The formulation utilizes a patented technology that allows its 15% urea concentration to achieve exfoliation efficacy comparable to 40% urea. Additionally, the cream contains proteolytic enzymes to assist in scale removal and hyaluronic acid to bind moisture to the skin. It is designed for twice-daily application, with therapeutic results typically observed within two weeks.
- Brand names
- Glycolix Glyco-Urea KP Therapy
- Other names
- Glycolic Acid 15% + Urea 15% OintmentAlpha Hydroxy Acid + Urea Ointment
Beyond the preview
Go deeper on Glycolix Glyco-Urea KP Therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glycolix Glyco-Urea KP Therapy.